Edition:
India

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

35.78USD
19 Jan 2018
Change (% chg)

$0.90 (+2.58%)
Prev Close
$34.88
Open
$34.82
Day's High
$35.84
Day's Low
$34.82
Volume
100,087
Avg. Vol
144,551
52-wk High
$46.81
52-wk Low
$28.49

Chart for

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $1,667.74
Shares Outstanding(Mil.): 43.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Repligen reports Q3 adjusted non-GAAP earnings per share $0.15

* Q3 earnings per share view $0.11 -- Thomson Reuters I/B/E/S

09 Nov 2017

BRIEF-Repligen extends long term supply agreement with Purolite for Protein A ligands

* Repligen extends long term supply agreement with Purolite for Protein A ligands

07 Nov 2017

BRIEF-Roy Eddleman reports 11 pct passive stake in Repligen‍​

* Roy T. Eddleman reports 11.0 percent passive stake in Repligen Corp as of August 1, 2017 - sec filing‍​ Source text: (http://bit.ly/2vRsiEb) Further company coverage:

21 Aug 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $147.36 +0.44
Novartis AG (NOVN.S) CHF83.38 +0.48
Roche Holding Ltd. (ROG.S) CHF234.50 +1.30
Roche Holding Ltd. (RO.S) CHF237.80 +1.00
Merck & Co., Inc. (MRK.N) $61.28 +0.15
Sanofi SA (SASY.PA) €72.95 +0.58
Amgen, Inc. (AMGN.OQ) $189.28 +1.69
Gilead Sciences, Inc. (GILD.OQ) $80.98 -0.19
Incyte Corporation (INCY.OQ) $93.16 +1.24

Earnings vs. Estimates